CUSIP: 64132K102
What is CUSIP 64132K102?
CUSIP 64132K102 identifies NBSE - NEUBASE THERAPEUTICS INC - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 64132K102:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q4 | 0 | $0 | -$40,855 | 0 | |
| 2023 Q3 | 46,970 | $40,855 | -$92,515 | $0.87 | 1 |
| 2023 Q2 | 97,070 | $180,349 | -$4,784,127 | $1.85 | 3 |
| 2023 Q1 | 9,274,985 | $1,716,550 | -$156,228 | $0.18 | 34 |
| 2022 Q4 | 10,043,919 | $1,909,872 | -$678,604 | $0.19 | 30 |
| 2022 Q3 | 11,993,655 | $4,738,950 | -$399,878 | $0.40 | 36 |
| 2022 Q2 | 12,754,808 | $13,374,698 | +$237,842 | $1.05 | 36 |
| 2022 Q1 | 12,369,723 | $23,255,000 | +$200,024 | $1.88 | 41 |
| 2021 Q4 | 11,232,940 | $31,563,000 | -$177,231 | $2.81 | 41 |
| 2021 Q3 | 10,126,744 | $36,562,000 | -$2,661,931 | $3.61 | 42 |
| 2021 Q2 | 10,754,154 | $51,513,000 | +$12,065,709 | $4.79 | 55 |
| 2021 Q1 | 8,035,085 | $59,379,950 | +$7,542,406 | $7.39 | 55 |
| 2020 Q4 | 7,020,478 | $49,079,000 | +$1,271,979 | $6.99 | 53 |
| 2020 Q3 | 6,714,677 | $50,965,490 | +$5,736,622 | $7.59 | 50 |
| 2020 Q2 | 5,869,250 | $51,532,262 | +$28,574,786 | $8.78 | 47 |
| 2020 Q1 | 2,705,870 | $19,266,152 | +$3,478,478 | $7.12 | 25 |
| 2019 Q4 | 2,216,574 | $15,957,120 | +$2,130,685 | $7.20 | 19 |
| 2019 Q3 | 1,927,245 | $9,616,000 | +$9,616,000 | $4.99 | 14 |